Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
07/30/2008 | CN101230069A Novel cephalosporin derivant |
07/30/2008 | CN101230067A Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors |
07/30/2008 | CN101230064A 9 methylene aryl substituted purine derivative |
07/30/2008 | CN101230043A 3-oxide-2-methylamide derivatives as well as preparation method and use thereof |
07/30/2008 | CN101230040A Process for preparing 17-allyl amino geldanamycin (17-AAG) and other ansamycins |
07/30/2008 | CN101229380A Targeted delivery of drugs for the treatment of viral infections |
07/30/2008 | CN101229371A Use of anti-TNFalpha antibodies and another drug |
07/30/2008 | CN101229360A Anti-AIDS medicine |
07/30/2008 | CN101229346A Capsule for hepatitis B |
07/30/2008 | CN101229343A Chinese traditional medicine for treating pulmonary tuberculosis |
07/30/2008 | CN101229342A Chinese traditional medicine for treating hepatitis with jaundice |
07/30/2008 | CN101229336A External used medicine for treating chronic eczema |
07/30/2008 | CN101229335A Method of enzyme method preparing smilax scobinicaulis total saponin extract |
07/30/2008 | CN101229333A External used Chinese traditional medicine preparation for treating verruca vulgaris and preparing method thereof |
07/30/2008 | CN101229331A Medicine for treating anorexia, limosis and preparing method thereof |
07/30/2008 | CN101229328A Method of extracting eucalyptus and bamboo wood flavonoid |
07/30/2008 | CN101229327A Medicine for treating chronic hepatitis b and preparing method thereof |
07/30/2008 | CN101229301A Chinese traditional medicine compounds for treating urinary system infection and prostatitis |
07/30/2008 | CN101229291A Chinese traditional medicine immunoregulation prescription for treating virus hepatitis and method thereof |
07/30/2008 | CN101229290A Chinese traditional medicine compounds for treating common cold and throat irritation, and preparing method thereof |
07/30/2008 | CN101229283A Zhongganling capsule and preparing method thereof |
07/30/2008 | CN101229251A Chinese traditional medicine for treating diarrhoea, bacillary dysentery and colonitis |
07/30/2008 | CN101229235A Process for preparing corydalis saxicola bunting total alkali |
07/30/2008 | CN101229231A Veterinary compound clove linimentum for eperythrozoonosis and preparing method thereof |
07/30/2008 | CN101229223A Applications of fructus psoraleae extractive on preparing antitumor medicines |
07/30/2008 | CN101229190A Method for preparing highly water-soluble cydiodine |
07/30/2008 | CN101229188A External medicine for onychomycosis |
07/30/2008 | CN101229184A Deoxyribonucleic retrogradation snippet compound and applications thereof |
07/30/2008 | CN101229182A Antibacterium compounds containing clindamycin hydrochloride |
07/30/2008 | CN101229179A Medicine compounds containing oil orange phlorizin-B and uses thereof |
07/30/2008 | CN101229178A Compound medicine compounds containing adefovir dipivoxil, preparing method and uses thereof |
07/30/2008 | CN101229168A Immunity excitant containing selenium |
07/30/2008 | CN101229164A Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
07/30/2008 | CN101229139A Cefathiamidine freeze-dried powder injection and preparing method thereof |
07/30/2008 | CN101229137A Gatifloxacin freeze-dried powder injection and preparing method thereof |
07/30/2008 | CN101229129A Ceftezole sodium powder injection and synthesizing method thereof |
07/30/2008 | CN101229128A Cefepime hydrochloride powder injection and preparing method thereof |
07/30/2008 | CN101229127A Liposome preparation |
07/30/2008 | CN101229126A Tinidazole compound nano silver microemulsion antibacterial medicine |
07/30/2008 | CN101229122A Zanamivir nasal in situ jellies with phase variation property and preparing method thereof |
07/30/2008 | CN101229121A Penciclovir microemulsion gel preparation and preparing method thereof |
07/30/2008 | CN101229102A Composition comprising particulate zinc materials having a defined crystallite size |
07/30/2008 | CN101228945A Ginger noodle and producing method thereof |
07/30/2008 | CN100406455C Oxazolidinone analog compound containing triazol radical and its preparation method and uses |
07/30/2008 | CN100406454C Pyrazole compounds useful as protein kinase inhibitors. |
07/30/2008 | CN100406449C CDC25 phosphatase inhibitors |
07/30/2008 | CN100406439C Pyrrolidine derivatives as metalloprotease inhibitors |
07/30/2008 | CN100406437C Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these |
07/30/2008 | CN100406065C Conjugates of glycosylated/galactosylated peptide, bifunctional linker and nucleotidic monomers/polymers, and related compositions and method of use |
07/30/2008 | CN100406064C Formulation for treating disease infected by helicobacter pylori |
07/30/2008 | CN100406062C Preparation process of autogenous high-immunity serum for treating post-weaning multi systemic wasting syndrome of baby pig |
07/30/2008 | CN100406060C Adjuvant composition |
07/30/2008 | CN100406025C Pharmacal use of sex steroid antagonist and sex steroid agonist |
07/30/2008 | CN100406017C Dioxolane thymine and combinations for use against 3TC/AZT resistant strains of HIV |
07/30/2008 | CN100406014C Famciclovir slow-releasing capsule for anti-virus treatment and its producing method |
07/30/2008 | CN100406004C Vaccine composition and method of using same |
07/29/2008 | US7405310 Non-nucleoside reverse transcriptase inhibitors |
07/29/2008 | US7405297 3-amino-2-ethoxycarbonylpyrrole; chemical intermediate in synthesis of 3H,5H-pyrrolo[3,2-d]pyrimidin-4-one; a convergent synthesis route rather than a linear one |
07/29/2008 | US7405276 First antigen recognition portion that binds a C3b-like receptor and a second that binds an antigenic molecule present in the circulatory system |
07/29/2008 | US7405273 Fusion protein of antigens from parainfluenza virus (PIV) and respiratory syncytial virus (RSV); single recombinant immunogen can protect susceptible individuals against diseases caused by both PIV and RSV |
07/29/2008 | US7405201 Antibacterial macrocycles |
07/29/2008 | US7405199 Chemical intermediate thereto; effective against antibiotic-resistant strains of bacteria, such as methicillin-resistant Staphylococci aureus (MRSA) |
07/29/2008 | US7405049 Elevated concentration of given protein is indicative of sepsis or Alzheimer's disease; procalcitonin biomarker; immunoassay |
07/29/2008 | US7405045 Retrieving ductal fluid samples from ducts using elongated lumen and detecting presence of papilloma, Epstein-barr and herpes virus |
07/29/2008 | US7404964 Complex of antibiotic and fatty acid; sustained release; extended release time, maximum stability and efficacy, reduced toxicity, maximum reproducibility in preparation, and the elimination of unwanted physical, biochemical, or toxicological effects introduced by undesirable matrix materials |
07/29/2008 | US7404960 Multivalent vaccine composition having increased stability of capsular polysaccharide |
07/29/2008 | CA2461921C Composition of hypochlorous acid and its applications |
07/29/2008 | CA2432222C Pyrazole compounds useful as protein kinase inhibitors |
07/29/2008 | CA2432132C Pyrazole compounds useful as protein kinase inhibitors |
07/29/2008 | CA2382322C Aminocarbonyl-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions |
07/29/2008 | CA2375601C Carbapenem compound crystals and injection preparations |
07/29/2008 | CA2375383C Modulators of methylation for control of bacterial virulence |
07/29/2008 | CA2362625C Frozen chlorine dioxide-containing composition and methods related thereto |
07/29/2008 | CA2348742C Carbocyclic potassium channel inhibitors |
07/29/2008 | CA2337755C Inhibitors of p38 |
07/29/2008 | CA2281817C Methods of use of fluoroquinolone compounds against maxillary sinus pathogenic bacteria |
07/29/2008 | CA2261835C Long-acting drugs and pharmaceutical compositions comprising them |
07/29/2008 | CA2254070C Method for treating viral infections |
07/25/2008 | CA2617463A1 Linear dicationic terphenyls and their aza analogues as antiparasitic agents |
07/24/2008 | WO2008089105A2 Antiviral nucleoside analogs |
07/24/2008 | WO2008089027A1 Compounds for the treatment of hepatitis c |
07/24/2008 | WO2008088822A1 Inhibiting staphylococcus epidermidis infections |
07/24/2008 | WO2008088538A2 Esters of 2-phenylalkanenitriles and antifungal compositions containing them |
07/24/2008 | WO2008088047A1 Method for glycosylation of flavonoid |
07/24/2008 | WO2008088033A1 Hiv-protease inhibitor and method for production thereof |
07/24/2008 | WO2008087933A1 NOVEL INDOLE DERIVATIVE HAVING INHIBITORY ACTIVITY ON IϰB KINASE β |
07/24/2008 | WO2008087441A2 An influenza prevention and treatment composition |
07/24/2008 | WO2008086730A1 Tetrahydroquinazoline compounds and their use in preparing medicaments for treating and preventing virosis |
07/24/2008 | WO2008086698A1 A forsythoside injection and preparation thereof |
07/24/2008 | WO2008086612A1 Hat acetylation promoters and uses of compositions thereof in promoting immunogenicity |
07/24/2008 | WO2008086610A1 Hat acetylation promoters and uses of compositions thereof in promoting immunogenicity |
07/24/2008 | WO2008068272A3 Antibacterial quinoline derivatives |
07/24/2008 | WO2008059258A3 Imidazoles for treating multi-drug resistant bacterial infections |
07/24/2008 | WO2008057196A3 Methods and compositions using immunomodulatory compounds for the treatment and management of spirochete and other obligate intracellular bacterial diseases |
07/24/2008 | WO2007080401A8 Triazoloanilinopyrimidine derivatives for use as antiviral agents |
07/24/2008 | US20080177217 Taurolidine Formulations and Delivery: Therapeutic Treatments and Antimicrobial Protection Against Bacterial Biofilm Formation |
07/24/2008 | US20080177064 Dipeptidyl peptidase inhibitors |
07/24/2008 | US20080176946 Formulations for cancer treatment |
07/24/2008 | US20080176944 Elongase Genes and Uses Thereof |
07/24/2008 | US20080176938 Modulation of pathogenicity |